Cargando…
Profile of pembrolizumab in the treatment of head and neck squamous cell carcinoma: design development and place in therapy
Head and neck squamous cell cancer (HNSCC) is the sixth most common malignancy worldwide, and despite advances in cytotoxic, surgical and radiation techniques, outcomes are still poor in those with both locally advanced and metastatic diseases. The need for development of better therapeutics along w...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587117/ https://www.ncbi.nlm.nih.gov/pubmed/28919706 http://dx.doi.org/10.2147/DDDT.S119537 |